Theolytics
Theolytics is an Oxford-based, clinical-stage biotechnology company developing intravenous oncolytic immunotherapies for solid tumours.
- Headquarters
- Oxford, England, United KingdomSource: RevenueBaseRetrieved October 13, 2026
- Employee range
- 11 to 50Source: RevenueBaseRetrieved October 13, 2026
- Founded
- 2017Source: RevenueBaseRetrieved October 13, 2026
- Published list appearances
- 12 supported appearances ↗Source: RevenueBase lists
What does Theolytics do?
Its proprietary Adenovo platform applies natural selection to an adenovirus library to identify candidates with novel biology. Lead candidate THEO-260 combines cancer-cell killing, cancer-associated fibroblast killing, and induction of anti-tumour immunity.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Theolytics works with clinical investigators, academic groups, and pharmaceutical and biotechnology partners.
Company lists.
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Share your recognition
Embeddable award for your website
Sources & data notes.
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 2, 2026, September 16, 2026, September 18, 2026, September 19, 2026, September 21, 2026 and October 8, 2026. How the company lists are built.
Something changed?
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
One company is just the start.
Explore more companies by name, headquarters and business focus.